For the Inventor, By the Inventor

Enter assignee name

Wiesbaden, Germany

Abbott Gmbh & Co Kg

USPTO Granted Patents = 140

% Expired Patents = 63.6

CIPO Patents = 15

EPO Patents = 47

Trademarks = 1

Forward Citations = 1,838

Loading Chart...

Loading Chart...

252 inventors (with patents filed for the assignee):

Liliane Unger (48 out of 125 patents)

Andreas Haupt (37 out of 70 patents)

Wilfried Lubisch (31 out of 83 patents)

4. Wilfried Martin Braje (31 out of 62 patents)

5. Wilfried Hornberger (28 out of 85 patents)

6. Andreas Kling (28 out of 73 patents)

7. Wolfgang Wernet (28 out of 52 patents)

8. Karla Drescher (26 out of 52 patents)

9. Sean Colm Turner (20 out of 49 patents)

10. Roland Grandel (19 out of 23 patents)

11. Wilhelm Amberg (16 out of 64 patents)

12. Udo Lange (15 out of 47 patents)

13. Herve Geneste (15 out of 23 patents)

14. Hervé Geneste (14 out of 33 patents)

15. Thorsten K Oost (13 out of 60 patents)

Core Competencies:

Phosphodiesterase Inhibitors

Vasopressin Receptor Ligands

Human Antibodies

Dopamine D3 Receptor

Calpain Inhibitors

Glycogen Synthase Kinase

Serotonin 5-HT6 Receptor

Antineoplastic Peptides

Oxindole Derivatives

Heterocyclic Compounds

Carboxylic Acid Derivatives

Pyridin-2-one Compounds

140 patents: Sort by Forward Citations

1. 9388180 - Inhibitor compounds of phosphodiesterase type 10A (2016-07-12),

2. 8859557 - Substituted oxindole derivatives and their use as vasopressin receptor ligands (2014-10-14),

3. 8815868 - Substituted oxindole derivatives and their use as vasopressin receptor ligands (2014-08-26),

4. 8765918 - Human antibodies that bind human interleukin-12 (2014-07-01),

5. 8580842 - Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing them (2013-11-12),

6. 8507469 - [object Object] (2013-08-13),

7. 8497273 - Heterocyclic compounds suitable for treating disorders that respond to modulation of the serotonin 5HT6 receptor (2013-07-30),

8. 8492540 - [object Object] (2013-07-23),

9. 8486984 - [object Object] (2013-07-16),

10. 8486931 - Substituted oxindole compounds (2013-07-16),

11. 8486456 - Itraconazole compositions with improved bioavailability (2013-07-16),

12. 8481576 - Guanidine compounds, and use thereof as binding partners for 5-HT5 receptors (2013-07-09),

13. 8476275 - N-[piperazinyl hetaryl]arylsufonamide compounds with affinity for the dopamine D3 receptor (2013-07-02),

14. 8470810 - Heterocyclic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor (2013-06-25),

15. 8455648 - 1-(7-(hexahydropyrrolo [3,4-c] pyrrol-2 (1H)-yl) quinolin-4-yl) -3- (pyrazin-2-yl) urea derivatives and related compounds as glycogen synthase kinase 3 (GSK-3) (2013-06-04),

Company Overview

Abbott GmbH & Co KG, based in Wiesbaden, Germany, specializes in the development and manufacturing of pharmaceutical compounds. The company focuses on innovative therapeutic areas, particularly in the fields of phosphodiesterase inhibitors, vasopressin receptor ligands, and human antibodies. Abbott's research extends to critical domains such as dopamine D3 receptor modulation, calpain inhibition, and the development of antineoplastic peptides, contributing to advancements in medical treatments and patient care.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

140 Patents

#4 in Wiesbaden

#437 in Germany

#5,792 in the World

Wiesbaden, Germany

Abbott Gmbh & Co Kg

Forward Citations = 1,838

252 inventors:

Liliane Unger (48 out of 125 patents)

Andreas Haupt (37 out of 70 patents)

Wilfried Lubisch (31 out of 83 patents)

4. Wilfried Martin Braje (31 out of 62 patents)

5. Wilfried Hornberger (28 out of 85 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Abbott Gmbh & Co Kg. Retrieved from https://idiyas.com/company/abbott-and-co-kg

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…